MONITORING OF SERUM MARKERS FOR FIBROSIS DURING CCL4-INDUCED LIVER-DAMAGE - EFFECTS OF ANTIFIBROTIC AGENTS

被引:37
作者
JIANG, Z
YOU, DY
CHEN, XC
WU, J
机构
[1] UMEA UNIV,DEPT HISTOL & CELL BIOL,S-90187 UMEA,SWEDEN
[2] NANJING RAILWAY MED COLL,DEPT INTERNAL MED,DIGEST DIS RES UNIT,NANJING,PEOPLES R CHINA
关键词
LIVER FIBROSIS; PROCOLLAGEN-III PEPTIDE; PROLIDASE; 16,16-DIMETHYL PROSTAGLANDIN-E2; COLCHICINE; ZINC SULFATE;
D O I
10.1016/S0168-8278(05)80658-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver fibrosis was induced in rats by repeated peritoneal injections of carbon tetrachloride (CCl4) over a period of 2-11 weeks. Serum procollagen III peptide (SPIIINP), prolidase (SP) and alanine aminotransferase (SALT) levels were monitored during the period of induction. The extent of fibrosis was semi-quantitatively estimated after collagen staining, and the anti-fibrotic effects of 16,16-dimethyl prostaglandin E2 (DMPGE2), colchicine, and zinc sulphate were studied. SPIIINP and SP were increased the first 2 weeks after CCl4 administration and peaked at 6 weeks. Alterations in SPIIINP and SP correlated well to the semi-quantitative histological score of liver sections during the first 6 weeks, and SP was positively related to SPIIINP throughout the whole induction period. DMPGE2 decreased SPIIINP, SP and SALT significantly in addition to a markedly decreased formation of liver collagens. Colchicine had a similar but less dramatic effect, whereas zinc sulphate only reduced SPIIINP without influencing liver damage. In conclusion SPIIINP seems to be a valuable indicator of liver fibrogenesis, and SP may play a limited role in indicating accelerated collagen metabolism in the liver. DMPGE2 obviously inhibited the production of collagens induced by CCl4. Colchicine also had an apparent effect on liver fibrosis, whereas zinc sulphate merely seemed to postpone it.
引用
收藏
页码:282 / 289
页数:8
相关论文
共 43 条
  • [1] 16,16-DIMETHYL PROSTAGLANDIN-E2 PREVENTS THE DEVELOPMENT OF FULMINANT-HEPATITIS AND BLOCKS THE INDUCTION OF MONOCYTE MACROPHAGE PROCOAGULANT ACTIVITY AFTER MURINE HEPATITIS-VIRUS STRAIN-3 INFECTION
    ABECASSIS, M
    FALK, JA
    MAKOWKA, L
    DINDZANS, VJ
    FALK, RE
    LEVY, GA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (03) : 881 - 889
  • [2] ALAKOKKO L, 1989, J LAB CLIN MED, V113, P177
  • [3] ANTTINEN H, 1984, GASTROENTEROLOGY, V86, P523
  • [4] INVOLVEMENT OF PROSTAGLANDIN-E AND ADENOSINE-3',5'-MONOPHOSPHATE IN LIPOPOLYSACCHARIDE-STIMULATED COLLAGENASE RELEASE BY RAT KUPFFER CELLS
    BHATNAGAR, R
    SCHADE, U
    RIETSCHEL, ET
    DECKER, K
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1982, 125 (01): : 125 - 130
  • [5] LIVER FIBROSIS AND EXTRACELLULAR-MATRIX
    BIAGINI, G
    BALLARDINI, G
    [J]. JOURNAL OF HEPATOLOGY, 1989, 8 (01) : 115 - 124
  • [6] CAMPS J, 1991, J HEPATOL S2, V13, P16
  • [7] THERAPEUTIC STRATEGIES FOR HEPATIC-FIBROSIS
    CHOJKIER, M
    BRENNER, DA
    [J]. HEPATOLOGY, 1988, 8 (01) : 176 - 182
  • [8] CHVAOIL M, 1973, EXP MOL PATHOL, V13, P186
  • [9] CLARK JG, 1982, J BIOL CHEM, V257, P8089
  • [10] GAMMA-INTERFERON TREATMENT INHIBITS COLLAGEN DEPOSITION IN MURINE SCHISTOSOMIASIS
    CZAJA, MJ
    WEINER, FR
    TAKAHASHI, S
    GIAMBRONE, MA
    VANDERMEIDE, PH
    SCHELLEKENS, H
    BIEMPICA, L
    ZERN, MA
    [J]. HEPATOLOGY, 1989, 10 (05) : 795 - 800